Literature DB >> 23821330

Aberrant splicing in neurological diseases.

Dairong Feng1, Jiuyong Xie.   

Abstract

Splicing of precursor messenger RNA (pre-mRNA) removes the intervening sequences (introns) and joins the expressed regions (exons) in the nucleus, before an intron-containing eukaryotic mRNA transcript can be exported and translated into proteins in the cytoplasm. While some sequences are always included or excluded (constitutive splicing), others can be selectively used (alternative splicing) in this process. Particularly by alternative splicing, up to tens of thousands of variant transcripts can be produced from a single gene, which contributes greatly to the proteomic diversity for such complex cellular functions as 'wiring' neurons in the nervous system. Disruption of this process leads to aberrant splicing, which accounts for the defects of up to 50% of mutations that cause certain human genetic diseases. In this review, we describe the different mechanisms of aberrant splicing that cause or have been associated with neurological diseases.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821330     DOI: 10.1002/wrna.1184

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  17 in total

Review 1.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

2.  Evolutionary emergence of a novel splice variant with an opposite effect on the cell cycle.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

3.  In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay.

Authors:  Gianna Ulzi; Valeria A Sansone; Francesca Magri; Stefania Corti; Nereo Bresolin; Giacomo P Comi; Sabrina Lucchiari
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

4.  Genome-wide evolution of wobble base-pairing nucleotides of branchpoint motifs with increasing organismal complexity.

Authors:  Hai Nguyen; Urmi Das; Jiuyong Xie
Journal:  RNA Biol       Date:  2019-12-19       Impact factor: 4.652

Review 5.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

6.  Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females.

Authors:  Jennifer M Bain; Megan T Cho; Aida Telegrafi; Ashley Wilson; Susan Brooks; Christina Botti; Gordon Gowans; Leigh Anne Autullo; Vidya Krishnamurthy; Marcia C Willing; Tomi L Toler; Bruria Ben-Zev; Orly Elpeleg; Yufeng Shen; Kyle Retterer; Kristin G Monaghan; Wendy K Chung
Journal:  Am J Hum Genet       Date:  2016-08-18       Impact factor: 11.025

Review 7.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

8.  Functional Implications of RNA Splicing for Human Long Intergenic Noncoding RNAs.

Authors:  Feng-Chi Chen; Chia-Lin Pan; Hsuan-Yu Lin
Journal:  Evol Bioinform Online       Date:  2014-12-10       Impact factor: 1.625

9.  Evolutionarily emerged G tracts between the polypyrimidine tract and 3' AG are splicing silencers enriched in genes involved in cancer.

Authors:  Muhammad Sohail; Wenguang Cao; Niaz Mahmood; Mike Myschyshyn; Say Pham Hong; Jiuyong Xie
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

10.  Upregulation of RBFOX1 in the malformed cortex of patients with intractable epilepsy and in cultured rat neurons.

Authors:  Ming Wen; Yong Yan; Ning Yan; Xiao Shan Chen; Shi Yong Liu; Zhan Hui Feng
Journal:  Int J Mol Med       Date:  2015-01-05       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.